Welcome to the investor relations center of Accelerate Diagnostics, Inc. Here you will find a wealth of information regarding the company’s performance to date, recent filings, and our strategy for the continued growth of our business.
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Our focus is developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
If you have questions or comments please contact our Investor Relations team by clicking here. We will be happy to help!
Jun 7, 2017
Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
May 30, 2017
Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
May 15, 2017
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
View Latest Presentation ›
Listen to the recent webcast
Day Low: 28.90